Spotlight
Obituaries
Classifieds
Families First
VCAs Best of Guide
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Recommended
Inside job: NC inmates accused of running phone scams targeting families for fake bail payments
Recommended
5 On Your Side catches grocery stores charging full price for sale items
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Voyager Acquisition Corp - Class A Ordinary Shares
(NQ:
VACH
)
10.39
UNCHANGED
Streaming Delayed Price
Updated: 1:06 PM EDT, Jul 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Voyager Acquisition Corp - Class A Ordinary Shares
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
July 17, 2025
From
Voyager Acquisition Corp.
Via
GlobeNewswire
BioMedNewsBreaks — VERAXA Biotech AG and Voyager Acquisition Corp. (NASDAQ: VACH, “Voyager”) Announce $1.64 Billion Business Combination to Create Clinical-Stage Cancer Therapy Powerhouse
June 10, 2025
Via
Investor Brand Network
VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
May 20, 2025
Industry Veteran to Support Acceleration of Key Pipeline Projects and Novel BiTAC™ Antibody Formats Towards Clinical Studies
From
VERAXA Biotech AG
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.